Business Wire

Technology Holdings Unveils the 'TH Growth and Exit Strategy Report' for your Tech Services, Consulting, BPO or Technology Business: Get a Customised Exit Readiness, Recapitalization and Growth Strategy Report in Minutes Powered by Strat

Share

Technology Holdings (TH), an award-winning global boutique investment bank with a presence in 12 countries across 5 continents, proudly announces the launch of the ‘TH Growth and Exit Strategy Report.’ This innovative report is designed specifically for businesses in IT Services, Consulting, Professional Services, Business Process Management, Technology and SaaS.

In just a few clicks, recipients will receive a customised report directly to their inbox, detailing their exit or recapitalization readiness and providing tailored recommendations for growth strategies. The report leverages TH’s 24 years of mergers and acquisitions, buy-out and growth advisory expertise and experience working with companies of all sizes combined with insights from management consultants.

Click here to complete the survey and receive the ‘TH Growth and Exit Strategy Report’, tailored for your business.

Using AI driven technology powered by Strat, Technology Holdings’ M&A experts have designed the survey to help businesses worldwide gain valuable insights into their current operational state and provide a roadmap for improving their business practices to attract potential investors or buyers. Upon completion, participants will receive a report with a “fit for sale” score, which is judged based on five sections of the report outlined below:

  • Financial Performance Overview: An analysis of a company’s financial health, showcasing trends in revenue and profitability margins. The section illustrates the company's capacity for sustainable financial success and growth potential.
  • Market Positioning and Value Proposition: This section provides insights into a company’s product offerings, highlighting competitive advantages such as brand reputation and commitment to innovation, and suggestions for improvement are provided, to better meet market demands.
  • Client Landscape: A comprehensive overview of the client base, including demographics, retention rates, and revenue contributions. The section emphasizes the importance of client satisfaction and identifies strategies for enhancing relationships and feedback mechanisms.
  • Operational Effectiveness: Evaluations of the operational model of a company, detailing the strengths and areas for improvement. The section discusses customer management processes, technology investments, and team dynamics, offering recommendations to optimize performance and efficiency.
  • Strategic Initiatives for Growth: Initiatives to drive future growth, including market expansion, enhanced digital marketing efforts, and employee development investments. These strategies are aimed at positioning companies for long-term success and increased market share.

Vivek Subramanyam, Founder and CEO of Technology Holdings, stated, “We’re excited to introduce the ‘TH Growth and Exit Strategy Report,’ our ‘Management Consultant in a Box’ tool designed to help businesses maximize value, minimize risk, enhance growth strategy, and prepare for a successful exit or recapitalization. We appreciate the support from the team at Strat in creating this innovative tool, which enables businesses to receive a customised and comprehensive report in just minutes.”

About Technology Holdings

Technology Holdings (TH) is a global boutique investment bank dedicated to delivering M&A and capital raising advisory services exclusively to technology services, software, consulting, healthcare, and business process management companies with enterprise values ranging from $25 million to $500 million USD. Established in 2000, Technology Holdings has a team of over 130 employees and a global presence in 12 countries across 5 continents, and a track record of closing transactions in 24 countries.

About Strat

Strat uses AI-driven technology designed to help businesses think strategically and focus on what truly matters. Strat has a suite of digital products that use predictive analytics and collective intelligence to set direction, pinpoint key success factors, and craft tailored plans that empower companies to win in competitive markets. Fully self-serve and accessible anytime, anywhere, the platform equips teams with tools, workflows, and frameworks to address their most pressing strategic issues while fostering collaboration and driving alignment. Strat is the technology arm of Rygur consulting, a boutique firm specialising in innovative solutions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241112361126/en/

Contacts

Haleigh Dhaou
PR Manager
haleigh@technologyholdings.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press Release

Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 100 points. TIME and Statista analyzed 3,000 major companies from 150 countries, focusing exclusively on those with trans

Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press Release

The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa

ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press Release

ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors (corner cube prisms) designed to reflect laser beams directly back to their source, regardless of the an

Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press Release

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai

Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye